Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01663493 · ClinicalTrials.gov registry record · NA
Comparing Methods to Biopsy Pancreas Mass
A NA study of Pancreas Mass Diagnosis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT01663493: Completed NA study of Pancreas Mass Diagnosis, sponsored by Brigham and Women's Hospital.
NCT01663493 is a NA study of Pancreas Mass Diagnosis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01663493, a NA study of Pancreas Mass Diagnosis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether there is any difference in number of passes needed to diagnose pancreatic masses during endoscopic ultrasound-guided biopsies using 2 different types of needles.
Conditions Studied
Interventions
- PROCEDURE FNB
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-02 |
| Phase | NA |
What the finished NCT01663493 record still lists
NCT01663493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Pancreas Mass Diagnosis appearing as the primary indexed condition, and to 1 intervention - of which FNB is the first listed.
NCT01663493 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01663493 about?
NCT01663493 is a clinical study titled "Comparing Methods to Biopsy Pancreas Mass". This study will examine whether there is any difference in number of passes needed to diagnose pancreatic masses during endoscopic ultrasound-guided biopsies using 2 different types of needles.
What is the current status of trial NCT01663493?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-10. Estimated completion is 2017-02.
What conditions does trial NCT01663493 study?
This clinical trial studies the following conditions: Pancreas Mass Diagnosis.
What interventions are being tested in trial NCT01663493?
The interventions under investigation include: FNB (PROCEDURE).
Who is sponsoring clinical trial NCT01663493?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01663493 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01663493's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia